Amylyx Pharmaceuticals (AMLX) FCF Margin (2021 - 2024)
Amylyx Pharmaceuticals' (AMLX) quarterly FCF Margin came in at 9281.13% in Q4 2024, up 926897.0% year-on-year from N/an in Q1 2024, and up 192.92% quarter-over-quarter from 9988.22% in Q3 2024.
Amylyx Pharmaceuticals (AMLX) FCF Margin (2021 - 2024) Analysis & Trends
Amylyx Pharmaceuticals' FCF Margin history runs 4 years deep, the most recent figure standing at 9281.13% for Q4 2024.
- On a quarterly basis, FCF Margin rose 926897.0% year-over-year to 9281.13% in Q4 2024; TTM through Sep 2025 was 24295.6%, a 2434374.0% increase from a year earlier, with the FY2024 full-year figure at 192.0%, down 19480.0% from the prior year.
- FCF Margin improved to 9281.13% in Q4 2024 per AMLX's latest filing, from 9988.22% in the prior quarter.
- Across five years, FCF Margin topped out at 9281.13% in Q4 2024 and bottomed at 12619.42% in Q3 2022.
- The 4-year median for FCF Margin is 7.45% (2023), against an average of 2494.63%.
- Across the five-year window, FCF Margin soared 1261404 bps in 2023 and sank 998284 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 7374.74% in 2021, then jumped by 97 bps to 229.92% in 2022, then jumped by 105 bps to 12.17% in 2023, then soared by 76181 bps to 9281.13% in 2024.
- Per Business Quant, the three latest AMLX FCF Margin figures stand at 9281.13% (Q4 2024), 9988.22% (Q3 2024), and 6517.01% (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Amylyx Pharmaceuticals | 1.94 Bn | 1.94 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 9,281.13% |
| Sep 30, 2024 | -9,988.22% |
| Jun 30, 2024 | -6,517.01% |
| Mar 31, 2024 | -0.63% |
| Dec 31, 2023 | 12.17% |
| Sep 30, 2023 | -5.38% |
| Jun 30, 2023 | 8.48% |
| Mar 31, 2023 | -7.45% |
| Dec 31, 2022 | -229.92% |
| Sep 30, 2022 | -12,619.42% |
| Sep 30, 2021 | -7,374.74% |